ImmuONE
PITCH
INNOVATIVE SOLUTIONS FOR INHALATION SAFETY ImmuONE specialises in human alveolar macrophage responses and epithelial cell culture platforms
LATEST INVESTMENT
#Biotech
10.2023
£2M
MEIF Proof of Concept & Early Stage Fund